U.S. Machinery Stock News

Warby Parker stock slipped about 1.9% today to US$26.46, extending a weaker run over the past three months, yet the latest quarter told a different story. The Q2 headline was profitability holding and earnings ticking higher, even as revenue came in at US$235.5m. Adjusted EBITDA of US$32.9m, helped by a one time tariff refund, gave the company more room to invest ahead of its Intelligent Eyewear push. For short term traders, the modest price drop will stand out. For longer term investors, the...

Keurig Dr Pepper stock slipped about 1% to US$30.01 after the Q2 earnings hit the tape, a muted reaction for a quarter that radically reshaped the story. The market seems more focused on a soft recent share price trend than on what just landed in the income statement. The real headline is profit pressure. Quarterly basic earnings per share came in at about US$0.04 on net income of US$60m against revenue of US$7.3b. That mix of heavy top line and light profit sits within a richer P/E and a...

Immunocore Holdings slipped 1.45% to US$34 after earnings, a modest move for a biotech that reported another quarter of solid product revenue and a near breakeven bottom line. The stock had quietly gained over the past three months, so today’s reaction appears more like a pause than a verdict. The key point is that KIMMTRAK helped drive Q2 revenue to US$115.9m while the company reported a net loss of only US$0.8m. For a high research and development oncology platform, that shrinking loss...

A surprise loss of 23,000 jobs in July and weaker past hiring have put the labour market under fresh scrutiny. Slower growth can shift expectations for interest rates, which often steers money toward sectors seen as more resilient. Healthcare stocks sit firmly in that conversation. This article walks through three larger healthcare companies from our screener that appear well positioned or vulnerable to these cross currents, so you can decide how they might fit your watchlist. The stocks in...

EPAM Systems stock jumped 4.7% to about US$97 in the first full session after earnings, a sharp move for a company that had been treading water over the past week. The headline was clear enough for the market. Q2 revenue came in around US$1.4b and non GAAP earnings per share reached US$3.38, helped by a non GAAP operating margin of 16.4%. Short term traders focused on that margin snapback. Long term holders will be weighing the slower full year revenue outlook against EPAM Systems’ push into...

The market clipped Citizens Financial Services by about 2.3% today, even though the earnings story looked steadier than the share price reaction suggests. Heading into the release, the stock had quietly added double digit returns over the past month and quarter, helped by a P/E of 9.4x that sits below both US banks and close peers. The headline this quarter is not revenue or earnings per share. It is credit quality. Non performing loans increased to just over US$41 million while the allowance...

Talkspace stock barely moved after earnings, ticking up just 0.2% to US$5.22. The quiet price action hides a more complicated picture. The online therapy provider is still posting quarterly losses, with Q2 basic earnings per share at roughly a US$0.01 loss and net income in the red. At the same time, the trailing twelve month figures show Talkspace hovering around break even profit and carrying a richer price to sales ratio than many healthcare peers. The key issue for investors is whether...

Targa Resources stock gave back 4.2% today and is down over the past month, even though the company just printed one of its most powerful profit runs yet. The disconnect starts with Q2 adjusted earnings power. Net income excluding special items reached US$764.6m on revenue of US$4.4b, while adjusted EBITDA hit US$1.603b, helped by record Permian volumes and downstream throughput. So the near term tape looks shaky, but the headline is clear. Targa Resources just put up a quarter that supports...

CVRx stock just suffered a brutal reset. Shares closed at US$2.39 after the earnings release, down almost 60% from the prior close, as investors reacted to a sharp cut in the 2026 revenue outlook and softer guidance for Q3. The headline from this quarter is not the top line. Revenue in Q2 reached US$15.7m with high gross margins of 87%, but the company still reported a net loss of US$14.0m and continues to run at a loss over the past year. The real question now is how long investors are...

Green Plains stock slipped 3.6% to US$14.65 after earnings, capping a three month stretch where the share price has trended lower. Yet the headline from this quarter is hard to square with that drift. Green Plains just posted one of its strongest profit quarters in years, with Q2 net income of US$67.1m and adjusted EBITDA of US$93.3m driven heavily by its growing carbon business. The short term tape suggests this is a tired biofuels stock. The multi year story now centers on a company that...

Organogenesis Holdings just watched its stock fall 22.8% to US$1.86, as investors reacted to another deep loss and a reset to the business outlook. The headline numbers are straightforward: revenue in Q2 came in at about US$43.8m, while the company reported a net loss of roughly US$99.3m. That is a heavy hit for a wound care specialist already under pressure. The short-term picture looks harsh. The longer-term question is whether today’s share price move already reflects a shrinking market,...

The market rushed to reward Arcturus Therapeutics Holdings with a 21.9% jump to US$7.41, yet the headline story is not a sudden profit turn. This is still a biotech posting a quarterly loss, with Q2 basic earnings per share at a loss of US$0.84. The real trigger for the move is a different kind of relief. Investors are reacting to a cleaner balance of risk and time. Arcturus ended June with US$191.5m in cash and guided to a runway into year end 2028. In a loss making drug developer, that kind...

Sunrise Realty Trust stock barely flinched after earnings, slipping only 0.6% to US$7.80, which leaves the recent 30 day drift slightly down and the 90 day move modestly up. That muted reaction sits awkwardly against a quarter where the real story sits in margins. Net income of US$3.1 million on US$5.3 million of revenue keeps Sunrise firmly in high margin territory, yet trails its own recent profitability. For a mortgage REIT that investors often value on payout strength, the key headline is...

Oportun Financial stock barely moved after earnings, up just 0.5% to US$8.09, which suggests the market has not really made up its mind. Yet the quarter itself was anything but quiet. Oportun booked US$191.3m of revenue and reported basic earnings per share of about US$0.18, marking another period in the black for a company that only recently turned the profitability corner. The standout element for this consumer lender was profit quality. Management highlighted adjusted EBITDA of US$49m and...

The market rushed to rewrite the EuroDry story before the ink on the earnings release was even dry. The stock jumped 16% to about US$34.70, after a sharp run over the past month, as investors reacted to a dry bulk owner that is suddenly generating real profits instead of red ink. The headline is simple. EuroDry turned a tough recent history into a powerful quarter, with Q2 2026 net income of US$6.6m on revenue of US$17.7m and basic earnings per share of US$2.36. The share price now sits close...

PubMatic stock jumped 31.9% to US$17.78, capping a sharp rerating after a stretch of indifferent trading. The move reflects one clear headline from this earnings print. The ad tech company reported Q2 revenue of US$78.6m and adjusted EBITDA of US$19.6m, putting double digit growth back on the table, even as it still reported a small net loss. For short term traders the price jump is the story. For longer term investors the key question is whether this return to growth and cash generation can...

Commerce.com came into this earnings print as a cheap, loss‑making ecommerce platform story with a stock that had already slipped around 29% over the past month. The immediate reaction was more selling, with the share price down about 5% to US$2.21, yet the quarter itself showed Commerce.com edging further out of the red. Revenue for Q2 landed at US$84.5m with net income modestly positive and non‑GAAP operating margin near 10%. Annual recurring revenue and free cash flow also moved in the...

Alarm.com Holdings came into this earnings print with the stock already on a steady run, up more than 20% over the past three months and closing at US$57.53 after a 2.2% gain on the day. The market leaned into the report. The question was whether the security and smart home platform could justify that confidence with real operating heft. The headline numbers were clear. Software as a service and license revenue reached US$188.8m and adjusted earnings before interest, tax, depreciation and...

ResMed came into this earnings print with a strong multi year profit story and a valuation that already looked modest against peers. The stock still dropped about 5% to around US$212 on the first full trading day after the release. That gap between long term belief and short term price tells you investors were looking for more than just another solid quarter. The headline this time is profitability. Non GAAP EPS reached US$2.95 in Q4 and US$12.00 to US$12.25 is now on the table for FY2027...

Maplebear just added more than 11% in a single session, yet the real story sits behind that price spike. Q2 revenue reached US$1.04b and net income landed at US$109m, solid numbers for an online grocery platform that still trades at a P/E of about 25x while some listed peers sit closer to 45x. Short term traders are reacting to the headline beat. Long term investors are looking at a stock that screens well below one discounted cash flow estimate and are weighing whether this quarter’s cash...

Commercial Metals (CMC) drew investor attention on August 5, 2026, after raising its equity buyback authorization by US$600 million to a total of US$1.45b. The move prompted fresh questions about capital allocation and valuation. See our latest analysis for Commercial Metals. The buyback announcement comes after a strong run in Commercial Metals’ stock, with a 30 day share price return of 21.02% and a 1 year total shareholder return of 40.73%, suggesting momentum has been building into the...

Acushnet Holdings slipped 0.6% to about US$93 in the first trading session after its second quarter report, even though the headline numbers looked built for a stronger reaction. Revenue for the quarter came in at roughly US$820m and earnings per share landed a little above US$2, powered by a sharp jump in golf equipment and a tariff refund boost. The short term move leaves the stock down over the past month but slightly up over three months. The real story now shifts to what this earnings...

In the past quarter, Lineage, Inc. reported second‑quarter 2026 sales of US$1,361 million, with net loss widening to US$29 million and basic loss per share from continuing operations increasing to US$0.13. Despite higher losses for both the quarter and first half of 2026, management highlighted raised full‑year same‑store NOI guidance and improving operational trends, including stronger physical occupancy and geographic diversification. With raised same‑store NOI guidance and plans to reduce...

Iovance Biotherapeutics stock finished the session up 2.1% at US$6.34, a measured move for a company that just posted its strongest quarter yet. The market’s first read seems cautious rather than euphoric, even with record Q2 revenue of US$99.3m and an all time high gross margin near 56% in a high spend biotech model. The real tension for you as an investor is simple: the share price is reacting to a single day of sentiment, while the earnings print points to improving loss per share and a...